MBIO: Mustang Bio, Inc. Stock

by  •  • Comments Off on MBIO: Mustang Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.51
Enterprise Value ($M) -2.72
Book Value ($M) 0.12
Book Value / Share 0.01
Price / Book 28.54
NCAV ($M) -6.27
NCAV / Share -0.61
Price / NCAV -0.56

Profitability (mra)
Return on Invested Capital (ROIC) -19.69
Return on Assets (ROA) -0.70
Return on Equity (ROE) -1.73

Liquidity (mrq)
Quick Ratio 0.74
Current Ratio 0.74

Balance Sheet (mrq) ($M)
Current Assets 11.35
Assets 17.74
Liabilities 17.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -50.73
Net Income -51.60
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -49.48
Cash from Investing 5.89
Cash from Financing -26.08

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 21,689 120,676 17.97
2024-04-22 52,079 31,991 162.79
2024-04-19 21,236 26,887 78.98
2024-04-18 70,294 30,416 231.11

(click for more detail)

Similar Companies
LSDI – Lucy Scientific Discovery Inc. LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc. MBRX – Moleculin Biotech, Inc.
MEIP – MEI Pharma, Inc.


Financial data and stock pages provided by
Fintel.io